Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR9 | Q9NR96 | 7/20 | 0.35 |
| ▸ | TLR7 | Q9NYK1 | 7/20 | 0.35 |
| ▸ | DRD2 | P14416 | 6/20 | 0.34 |
| ▸ | DRD4 | P21917 | 5/20 | 0.34 |
| ▸ | DRD3 | P35462 | 3/20 | 0.34 |
| ▸ | TLR8 | Q9NR97 | 4/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.33 |
| ▸ | TRPV6 | Q9H1D0 | 4/20 | 0.33 |
| ▸ | PARP1 | P09874 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5720129 | 0.89 | TLR9 (0.35) | TLR9TLR7DRD2DRD4DRD3 | |
| SCHEMBL5720269 | 0.89 | DRD2 (0.39) | TLR9TLR7DRD2DRD4DRD3 | |
| SCHEMBL5720110 | 0.84 | TLR9 (0.40) | TLR9TLR7DRD2DRD4DRD3 | |
| SCHEMBL5719999 | 0.83 | CHRM2 (0.45) | TLR9TLR7DRD2DRD4DRD3 | |
| SCHEMBL5720185 | 0.81 | DRD2 (0.34) | TLR9TLR7DRD2DRD4DRD3 | |
| SCHEMBL5720295 | 0.81 | ALDH1A1 (0.36) | CHRM1 | |
| SCHEMBL5720128 | 0.80 | TLR7 (0.44) | TLR9TLR7DRD2DRD4DRD3 | |
| SCHEMBL5720388 | 0.79 | DRD2 (0.40) | TLR9TLR7DRD2DRD4DRD3 | |
| SCHEMBL5720132 | 0.78 | TRPV6 (0.41) | TLR9TLR7DRD2DRD4DRD3 | |
| SCHEMBL5720125 | 0.78 | CHRM1 (0.41) | TLR9TLR7DRD2DRD4DRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1515722-A4 | OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION | MERCK & CO INC (US) | 2006-06-21 | — | — | EP | claimed |
| EP-1515722-A2 | OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION | Merck & Co., Inc. (US) | 2005-03-23 | — | — | EP | claimed |
| WO-2003105781-A2 | OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION | MERCK & CO., INC. (US) | 2003-12-24 | — | — | WO | claimed |
| EP-1515722-A4 | OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION | MERCK & CO INC (US) | 2006-06-21 | — | — | EP | disclosed |
| EP-1515722-A2 | OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION | Merck & Co., Inc. (US) | 2005-03-23 | — | — | EP | disclosed |
| WO-2003105781-A2 | OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION | MERCK & CO., INC. (US) | 2003-12-24 | — | — | WO | disclosed |